On July 18, 2025, GSR, a key player in crypto capital markets, announced a $100 million investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP). This collaboration aims to position Litecoin (LTC) as a treasury asset, with GSR acting as a strategic advisor and digital asset treasury manager. GSR will collaborate with Litecoin's creator, Charlie Lee, who will join MEI's Board of Directors, alongside a GSR representative. This partnership aligns with MEI's new mission and follows its review of strategic alternatives. Lee emphasized Litecoin's decade-long stability and its integration into retail and payment systems. The partnership marks a significant step in bridging public markets with crypto innovation, enhancing institutional confidence in LTC. GSR's involvement as an investor and asset manager is expected to drive LTC's growth in decentralized finance. The collaboration also includes participation from various crypto venture capital firms, showcasing GSR's commitment to the digital asset ecosystem and its support for emerging projects. Read more AI-generated news on: https://app.chaingpt.org/news